CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- 4 Shares withheld for taxes EVP & General Counsel gave up 517 shares (to pay taxes)
- 4 Open-market sale EVP & General Manager US sold 43,993 shares at an average $83.49 ($3,672,887)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 280 shares (grant or award)
- 4 Grant or award Director acquired 240 shares (grant or award)
- 4 Grant or award Director acquired 249 shares (grant or award)
- 4 Grant or award Director acquired 326 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 389,080 shares at an average $72.24 ($28,107,770)
- 4 Open-market buy Director bought 525,804 shares at an average $67.96 ($35,734,890)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 1,177 shares (to pay taxes)
- 4 Open-market buy Director bought 1,598,374 shares at an average $66.91 ($106,952,404)
- 4 Open-market sale EVP, General Manager, Europe sold 7,375 shares at $74.19 ($547,151)
- 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 78 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Manager, Europe gave up 78 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 20 of 82 · 1,628 filings